Literature DB >> 17045435

Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.

S Sotthivirat1, J L Haslam, V J Stella.   

Abstract

The goal of this study was to evaluate alternative salt forms of (SBE)7M-beta-CD (currently the sodium salt). The potential salt form would ideally decrease the rate of (SBE)7M-beta-CD release from osmotic pump formulations and result in an increase in the rate and extent of drug release in osmotic pump tablet and pellet dosage forms. Several (SBE)7M-beta-CD salt forms (potassium, calcium, and two ethylene diamine salt forms) were prepared by either titration or ultrafiltration and characterized by elemental analysis and capillary electrophoresis, CE. The physical properties (water uptake behavior, osmolality, complexation characteristics, etc.) were then compared to the sodium salt form. Although the water isotherm and the binding characteristics using various model drugs were similar among all the salt forms, the calcium salt form appeared to be the best alternative candidate due to its lower osmolality and slower intrinsic dissolution rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045435     DOI: 10.1016/j.ijpharm.2006.08.046

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Inclusion complex of lurasidone hydrochloride with Sulfobutylether-β-cyclodextrin has enhanced oral bioavailability and no food effect.

Authors:  Jin Wang; Binbin Huang; Jie Dai; Guoguang Chen; Lili Ren
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection.

Authors:  Jason Wallach; James Gamrat; Rebekah Jauhola-Straight; Jeffrey Becker; Thomas Eckrich
Journal:  Pharmaceutics       Date:  2022-03-03       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.